<?xml version="1.0" encoding="utf-8"?>
    <rss version="2.0">
      <channel xmlns:content="http://purl.org/rss/1.0/modules/content/">
        <title>Frontiers in Genetics | Stem Cell Research section | New and Recent Articles</title>
        <link>https://www.frontiersin.org/journals/genetics/sections/stem-cell-research</link>
        <description>RSS Feed for Stem Cell Research section in the Frontiers in Genetics journal | New and Recent Articles</description>
        <language>en-us</language>
        <generator>Frontiers Feed Generator,version:1</generator>
        <pubDate>2026-05-11T14:05:48.748+00:00</pubDate>
        <ttl>60</ttl>
        <item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2026.1786528</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2026.1786528</link>
        <title><![CDATA[Lyar contributes to cell cycle progression and multi-lineage differentiation in mouse embryonic stem cells]]></title>
        <pubdate>2026-03-20T00:00:00Z</pubdate>
        <category>Brief Research Report</category>
        <author>Yuanqing Pan</author><author>Yuqi Su</author><author>Li Xing</author><author>Mingze Yao</author>
        <description><![CDATA[Ly-1 antibody reactive clone gene (Lyar) is involved in the regulation of embryonic stem cell (ESC) self-renewal. To explore the specific role of Lyar in cell cycle progression and embryonic differentiation, we generated Lyar knockout (KO) mouse ESC (mESC) lines using CRISPR/Cas9, and investigated the effects of Lyar deficiency on mESC proliferation, cell cycle, apoptosis and multi-lineage differentiation. We found that Lyar deficiency reduces proliferation, increases apoptosis, and elevates p53 and p21 protein expression. The impaired mESC proliferation is associated with the increased apoptosis and cell cycle progression defect, which is driven by p53-p21 pathway activation. In embryoid body (EB) formation assay, loss of Lyar led to significant downregulation of most germ layer-specific markers in KO mESC clones, including mesoderm (Gsc, T), endoderm (Gata4, Sox17) and ectoderm marker Pax6. These findings confirm that Lyar is required for cell cycle progression, proliferation, and lineage-specific marker expression during early differentiation, demonstrating that Lyar may serve as a critical regulatory factor in stem cell biology.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2026.1774170</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2026.1774170</link>
        <title><![CDATA[Functional validation of the novel KIF5A p.R17Q VUS reveals defective axonal transport in iPSC-motoneurons from a SPG10 patient]]></title>
        <pubdate>2026-02-27T00:00:00Z</pubdate>
        <category>Brief Research Report</category>
        <author>Serena Santangelo</author><author>Valeria Casiraghi</author><author>Claudia Fallini</author><author>Sabrina Invernizzi</author><author>Silvia Peverelli</author><author>Martina Bertocchi</author><author>Monica Feole</author><author>Marta Cozzi</author><author>Stefania Magri</author><author>Angelo Poletti</author><author>Patrizia Bossolasco</author><author>Franco Taroni</author><author>Vincenzo Silani</author><author>Antonia Ratti</author>
        <description><![CDATA[Cytoskeletal alterations and axonal transport deficits are key factors in many neurodegenerative disorders. The neuronal kinesin family member 5A (KIF5A) is a microtubule-based motor protein critical for anterograde transport of RNA granules, organelles, and neurofilaments along axons and dendrites. Heterozygous missense and nonsense mutations in the N-terminal motor and stalk domains are associated with hereditary spastic paraplegia 10 (SPG10) and Charcot-Marie-Tooth disease type 2 (CMT2), while frameshift mutations in KIF5A C-terminal cargo-binding domain are linked to amyotrophic lateral sclerosis (ALS). We recently reprogrammed an iPSC line from a SPG10 patient carrying the novel missense variant c.50G>A (p.R17Q) in the KIF5A motor domain, classified as variant of unknown significance (VUS) and predicted to affect ATP binding. Here we gene-edited this mutant iPSC line by CRISPR-Cas9 to obtain an isogenic wild-type (WT) KIF5A cell line. We next examined functionally the impact of the p.R17Q VUS on KIF5A protein sub-cellular distribution and on axonal transport of mitochondria and lysosomes in differentiated iPSC-motoneurons (MNs). The presence of neurofilament-positive axonal swellings and an increased distribution of KIF5A protein in distal neurites was observed in the mutant p.R17Q compared to the WT KIF5A iPSC-MNs, indicating a likely defective axonal transport. The anterograde velocity and distance travelled by mitochondria and lysosomes along neurites was indeed significantly reduced in the mutant KIF5A iPSC-MNs compared to the WT ones. These findings demonstrate that the p.R17Q VUS is pathogenic, thereby extending the spectrum of KIF5A mutations causing SPG10 and support the use of patient-derived iPSC-MNs to functionally validate KIF5A-associated VUS.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1713817</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1713817</link>
        <title><![CDATA[RNA-seq analysis reveals a positive role for NGF in the myogenic differentiation of bovine skeletal muscle satellite cells]]></title>
        <pubdate>2026-01-21T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Xin Li</author><author>Zhongli Zhao</author><author>Yang Cao</author><author>Yumin Zhao</author><author>Lihong Qin</author>
        <description><![CDATA[In this study, we successfully isolated and cultured bovine skeletal muscle satellite cells (bSMSCs) and induced muscle cell formation in vitro. Skeletal muscle satellite cells (SMSCs) were isolated from the deep tissues of foetal bovine hind limbs and differentiated with 2% horse serum in vitro. The transcriptome sequencing results revealed a total of 1030 differentially expressed genes (DEGs) in the middle stage of differentiation (day 3) compared with the predifferentiation stage (day 0). A total of 374 DEGs were identified in the postdifferentiation stage (day 7) compared with the middle differentiation stage (day 3). We further investigated the regulatory effects of the DEG nerve growth factor (NGF) on the proliferation and myogenic differentiation of bSMSCs. The overexpression of NGF increased the mRNA and protein expression levels of myosin heavy chain (MyHC) and myogenin (MyoG), which are myoblast development markers, whereas NGF knockdown had the opposite effect; however, NGF did not affect the expression of the proliferation marker paired box gene 7 (Pax7) in bSMSCs. In addition, functional enrichment analysis of the DEGs revealed that the PI3K/Akt signalling pathway was significantly enriched in the DEGs and that NGF regulates myogenesis through the activation of the PI3K/Akt signalling pathway. Our results revealed that NGF was shown to be a putative regulator that controls myogenesis by activating the PI3K/Akt signalling pathway. The study provided a reference for further studies on the molecular mechanism of myogenic differentiation, regulatory network establishment, and beef quality improvement.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1701001</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1701001</link>
        <title><![CDATA[Comparative RNA-seq and functional assays identify L-arginine transporter SLC7A2 as a potential regulator of osteogenesis in maxillary sinus mucosal stem cells]]></title>
        <pubdate>2025-10-28T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Jing Ren</author><author>Ningbo Geng</author><author>Tianren Zhou</author><author>Shiting Mo</author><author>Chi Zhang</author><author>Wei Peng</author><author>Chunhui Liao</author><author>Songling Chen</author>
        <description><![CDATA[BackgroundThe osteogenic differentiation of maxillary sinus mucosal stem cells (MSMSCs) plays a critical role in maxillary sinus floor elevation, yet its underlying regulatory mechanisms remain unclear. In addition, although both MSMSCs and palatal mesenchymal stem cells (PMSCs) may participate in bone regeneration, their osteogenic differentiation characteristics and molecular regulation differences have not been systematically analyzed. Therefore, the study aimed to characterize the transcriptional differences between MSMSCs and PMSCs during osteogenesis and identify the role of solute carrier family 7 member 2 (SLC7A2) in MSMSCs’ osteogenic differentiation.MethodsRNA sequencing (RNA-Seq) was conducted to compare gene expression profiles of MSMSCs and PMSCs at baseline (day 0) and 7, 14, and 21 days after osteogenic induction. Osteogenic differentiation was evaluated using Alkaline Phosphatase (ALP) staining, Alizarin Red S (ARS) staining, Western blotting, and quantitative polymerase chain reaction (qPCR) for the osteogenic markers osteocalcin (OCN), runt-related transcription factor 2 (RUNX2), and bone morphogenetic protein 2(BMP2). A lentiviral-based SLC7A2-silencing model was established in MSMSCs to silence SLC7A2 expression and thereby investigate its role in osteogenic differentiation.ResultsMSMSCs and PMSCs exhibited similar osteogenic gene expression patterns, but their underlying regulatory mechanisms differed. Notably, amino acid metabolism-related pathways were significantly enriched in MSMSCs during osteogenesis. SLC7A2 was identified as one of the top 10 differentially expressed genes (DEGs) common to MSMSCs at baseline (day 0) and 7, 14, and 21 days after osteogenic induction (FDR <0.05 and |log2FC| ≥2.0). Functional experiments further demonstrated that SLC7A2 knockdown in MSMSCs resulted in a significant decrease in ARS staining and ALP activity, and significantly suppressed the expression of OCN and RUNX2 compared to the control shEV group (P < 0.05, n = 3).ConclusionThe osteogenic differentiation of MSMSCs is tightly associated with amino acid metabolism.Notably, SLC7A2—an L-arginine transporter—is a gene required for the efficient osteogenic differentiation of MSMSCs. This study provides novel evidence to advance our understanding of the molecular mechanisms underlying stem cell osteogenic differentiation during maxillary sinus floor lifting surgery,and further suggests that SLC7A2 may serve as a potential target to enhance the efficacy of MSMSCs-based bone regeneration.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1639756</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1639756</link>
        <title><![CDATA[Mesenchymal stem cells and exosomes in ischemic brain injury: a review]]></title>
        <pubdate>2025-08-29T00:00:00Z</pubdate>
        <category>Mini Review</category>
        <author>Haiyan Xu</author><author>Lanlan Yang</author><author>Weitie Wang</author><author>Chengwei Zhang</author>
        <description><![CDATA[Stroke poses a serious threat to human health and life, serving as a leading cause of death and disability in adults. The incidence rate of stroke continues to rise annually. Following the onset of ischemic stroke, most patients experience a period of spontaneous recovery. Neural repair after cerebral ischemia is closely associated with neurovascular plasticity, which facilitates the regeneration and repair of nerves and blood vessels in the ischemic injury area. Mesenchymal stem cells (MSCs), adult stem cells isolated from bone marrow or other tissues, can differentiate into various cell types and possess characteristics such as self-renewal, low immunogenicity, and easy of isolation. Exosomes are regarded as the primary mediators of MSC functions. These specialized extracellular vesicles play critical roles in intercellular communication, targeted transport, and regulation of recipient cell functions through their surface molecules and cargo (e.g., proteins, RNA, and other bioactive factors). Studies demonstrate that MSCs and their exosomes participate in both neuronal and vascular endothelial cell damage and repair after stroke. They exert distinct effects at different stages of cerebral ischemia injury, promoting angiogenesis, neurogenesis, and reducing inflammation. While preclinical studies show promising therapeutic potential, clinical translation faces challenges such as standardization of exosome isolation, optimal dosing, delivery methods, and long-term safety evaluation. Future research should focus on overcoming these barriers to facilitate their application in stroke therapy. This review summarizes current research on the therapeutic potential of MSCs and their exosomes in ischemic brain injury.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1628178</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1628178</link>
        <title><![CDATA[Loss of dynamin 1-like protein impairs mitochondrial function and self-renewal, and activates the integrated stress response in human embryonic stem cells]]></title>
        <pubdate>2025-07-28T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Artur Cieslar-Pobuda</author><author>Safak Caglayan</author>
        <description><![CDATA[Dynamin 1-like protein (DNM1L/DRP1) is a crucial regulator of mitochondrial fission in cells and pathogenic mutations in DNM1L are linked to developmental and metabolic disorders in humans. While the role of DNM1L has been described in patient-derived fibroblasts, its function in early human development remains unclear. In this study, we generated DNM1L deficient human embryonic stem cells (hESCs) using CRISPR/Cas9 to investigate the consequences of DNM1L deficiency and impaired mitochondrial fission on stem cell function. DNM1L−/− hESCs exhibited hyperfused mitochondrial networks, reduced mitochondrial membrane potential, and elevated oxidative stress, indicating compromised mitochondrial fitness. Functionally, DNM1L−/− hESCs showed diminished self-renewal, and reduced expression of the core pluripotency factor OCT4, while NANOG expression was unaffected. We further found that differentiation potential toward the early ectodermal lineage was impaired, whereas early endodermal and mesodermal differentiation remained intact. Notably, integrated stress response (ISR) pathway was activated in DNM1L−/− hESCs, as shown by increased phosphorylated eIF2a and upregulation of downstream targets including activating transcription factor 4 (ATF4), ATF3, ATF5, and DDIT3. Restoring DNM1L expression by reintroduction of DNM1L into the AAVS1 locus rescued mitochondrial morphology and function, normalized ISR activation, and restored self-renewal and OCT4 expression in DNM1L−/− hESCs. These findings demonstrate that DNM1L is essential for maintaining mitochondrial homeostasis, stress response, self-renewal, and pluripotency in hESCs, and emphasize the importance of mitochondrial fission in stem cell function.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1658563</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1658563</link>
        <title><![CDATA[Correction: Reduced T-cell stemness underlies Th17 expansion and graft dysfunction in kidney transplant recipients]]></title>
        <pubdate>2025-07-15T00:00:00Z</pubdate>
        <category>Correction</category>
        <author>Chang Liu</author><author>Hao Jiang</author><author>Andu Zhu</author><author>Chen Xu</author><author>Zhenfan Wang</author><author>Guocai Mao</author><author>Minjun Jiang</author><author>Jianchun Chen</author><author>Zheng Ma</author><author>Jiaqian Qi</author><author>Zhijun Cao</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1588941</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1588941</link>
        <title><![CDATA[Reduced T-Cell stemness underlies Th17 expansion and graft dysfunction in kidney transplant recipients]]></title>
        <pubdate>2025-06-13T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Chang Liu</author><author>Hao Jiang</author><author>Andu Zhu</author><author>Chen Xu</author><author>Zhenfan Wang</author><author>Guocai Mao</author><author>Minjun Jiang</author><author>Jianchun Chen</author><author>Zheng Ma</author><author>Jiaqian Qi</author><author>Zhijun Cao</author>
        <description><![CDATA[IntroductionEnd-stage renal disease (ESRD) is increasing worldwide, and although kidney transplantation improves survival, long-term graft loss–driven mainly by immune-mediated rejection–remains common. We aimed to delineate immune mechanisms that distinguish recipients with stable versus impaired graft function.MethodsPeripheral blood mononuclear cells from kidney-transplant recipients with normal (n = 10) or impaired (n = 10) renal function were profiled by single-cell RNA sequencing. Fourteen immune populations were identified; CD4+ T-cell “stemness” was quantified using mRNAsi and EREG_mRNAsi indices, lineage trajectories were reconstructed with Monocle, and ligand–receptor communication was inferred with iTalk. Findings were validated in an independent bulk RNA-seq cohort (n = 192) using differential expression and weighted gene co-expression network analysis (WGCNA).ResultsRecipients with graft dysfunction exhibited (i) expansion of Th17 cells and contraction of Treg cells, (ii) significant loss of CD4+ T-cell stem-like features (lower mRNAsi/EREG_mRNAsi, p < 0.001), and (iii) pseudotime trajectories skewed toward Th17 differentiation. iTalk revealed enhanced S100A8/A9-TLR4 signalling from myeloid cells to neutrophils, consistent with reduced circulating neutrophils and presumptive intragraft accumulation. Bulk validation confirmed the stemness deficit and identified eight hub genes (API5, CAPRIN1, CCT2, DLG1, NMD3, RDX, SENP7, S100A4) that correlated with both low stemness and poor clinical outcome. Pathway enrichment implicated cell-morphogenesis, tight-junction, and metabolic-homeostasis pathways in graft injury.DiscussionIntegrative single-cell and bulk analyses link diminished CD4+ T-cell stemness, Th17-dominant polarization, and S100A4-mediated neutrophil recruitment to graft dysfunction. These signatures nominate stemness indices, Th17/Treg balance, and the S100-TLR4 axis as candidate biomarkers and therapeutic targets to preserve allograft integrity and prolong transplant survival.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1592599</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1592599</link>
        <title><![CDATA[Gene expression profiles identify key factors in inflammatory odontoblastic dental pulp stem cell differentiation via TNFα/C5L2]]></title>
        <pubdate>2025-06-04T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Muhammad Irfan</author><author>Ji Hyun Kim</author><author>Sreelekshmi Sreekumar</author><author>Seung Chung</author>
        <description><![CDATA[IntroductionInflammation is a complex host response to harmful infections or injuries, playing beneficial and detrimental roles in tissue regeneration. Notably, clinical dentinogenesis associated with caries development occurs within an inflammatory environment. Reparative dentinogenesis is closely linked to intense inflammation, which triggers the recruitment and differentiation of dental pulp stem cells (DPSCs) into the dentin lineage. Understanding how inflammatory responses influence DPSCs is essential for elucidating the mechanisms underlying dentin and pulp regeneration.MethodsGiven the limited data on this process, a broad approach is employed here to understand better the complex mechanisms involved and identify downstream signaling targets. This study investigates the role of inflammation and the complement receptor C5L2 in the odontoblastic differentiation of DPSCs and the associated transcriptomic changes using poly-A RNA sequencing (RNA-seq). RNA-seq techniques provide insight into the transcriptome of a cell, offering higher coverage and greater resolution of its dynamic nature.ResultsFollowing inflammatory stimulation, DPSCs exhibit significantly altered gene profiles, including marked up-regulation of key odontogenic genes, highlighting the critical role of inflammation in dentinogenesis. We demonstrate that TNFα-treated, odontoblast-like differentiating DPSCs, under C5L2 modulation, show differentially expressed gene profiles and transcriptomic changes.ConclusionBeyond quantifying gene expression, RNA-seq data also enable the discovery of novel transcripts, the identification of alternatively spliced genes, and the detection of allele-specific expression. The data presented may offer new avenues for experimental approaches to uncovering pathways in dentinogenesis by identifying specific transcription factors and gene profiles.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1584095</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1584095</link>
        <title><![CDATA[IGF-1 secreted by mesenchymal stem cells affects the function of lymphatic endothelial progenitor cells: a potential strategy for the treatment of lymphedema]]></title>
        <pubdate>2025-05-21T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Zekuan Xue</author><author>Dongdong Yang</author><author>Zhiwei Jin</author><author>Yijie Li</author><author>Yunfei Yu</author><author>Xinchun Zhao</author><author>Yongzhou Huang</author><author>Shengqiu Jia</author><author>Tong Zhang</author><author>Guilin Huang</author><author>Jixue Hou</author>
        <description><![CDATA[Mesenchymal stem cells (MSCs) can participate in lymphangiogenesis through paracrine effects, while lymphatic endothelial progenitor cells (LEPCs), a subpopulation of endothelial progenitor cells (EPCs), can differentiate into mature lymphatic endothelial cells, thereby influencing lymphatic function. In the present study, we investigated the mechanism by which MSCs regulate the activity of LEPCs through paracrine effects and preliminarily explored the possibility of the two types of cells working together to treat lymphovascular diseases. After isolation of MSCs and LEPCs from the bone marrow of C57BL/6 J mice, in vitro experiments verified that insulin-like growth factor 1 (IGF-1) secreted by MSCs activated the PI3K/Akt/mTOR pathway to promote the proliferation of LEPCs; IGF-1 decreased the rate of apoptosis and affected the cycle progression of LEPCs and the nucleotide metabolism levels. The therapeutic efficacy of combined transplantation of MSCs and LEPCs was shown to be superior to that of transplantation of LEPCs alone in murine hindlimb lymphedema models. These results suggest that MSCs significantly promote the proliferation of LEPCs through the activation of the PI3K/Akt/mTOR pathway in LEPCs by secreting IGF-1, and that IGF-1 also inhibits apoptosis and regulates cell metabolism. Combined transplantation of MSCs and LEPCs provides an experimental rationale and potential strategy for cell therapy in lymphedema.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1583391</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1583391</link>
        <title><![CDATA[Frontier progress and translational challenges of pluripotent differentiation of stem cells]]></title>
        <pubdate>2025-04-28T00:00:00Z</pubdate>
        <category>Mini Review</category>
        <author>Zhengbing Su</author><author>Hui Dong</author><author>Xiang Fang</author><author>Wenli Zhang</author><author>Hong Duan</author>
        <description><![CDATA[Stem cell research has significantly transformed regenerative medicine, with pluripotent stem cells (PSCs) serving as the cornerstone for disease modeling, drug screening, and therapeutic applications. Embryonic stem cells (ESCs) exhibit unparalleled self-renewal and tri-lineage differentiation, while induced pluripotent stem cells (iPSCs) bypass ethical constraints through somatic cell reprogramming. Clinical trials highlight the potential of mesenchymal stem cells (MSCs) in osteoarthritis and graft-versus-host disease, which leverage their immunomodulatory and paracrine effects. Despite advancements, challenges persist: iPSCs face epigenetic instability and tumorigenic risks, and adult stem cells struggle with inefficient differentiation. This paper systematically reviews stem cell source classification, differentiation regulatory mechanisms, cutting-edge technologies such as CRISPR/Cas9, and explores field-specific controversies (e.g., epigenetic stability of iPSCs) and future directions (e.g., integration of organoids and biomaterials). By analyzing current progress and challenges, it provides a multidimensional perspective for stem cell research.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1574545</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1574545</link>
        <title><![CDATA[SAMHD1 knockout hiPSC model enables high lentiviral transduction efficiency in myeloid cell types]]></title>
        <pubdate>2025-04-07T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Huinan Li</author><author>Maliha Afroze</author><author>Gunisha Arora</author><author>Scot Federman</author><author>Kaivalya Shevade</author><author>Yeqing Angela Yang</author><author>Phuong Nguyen</author><author>Rustam Esanov</author><author>Laralynne Przybyla</author><author>Adam Litterman</author><author>Shawn Shafer</author>
        <description><![CDATA[Recent advances in functional genomics tools have ushered in a new era of genetic editing to identify molecular pathways relevant to developmental and disease biology. However, limited model systems are available that adequately mimic cell states and phenotypes associated with human disease pathways. Here, we quantitatively analyzed the founder population bottleneck effect and demonstrated how the population changes from human induced pluripotent stem cells (hiPSCs) to hematopoietic stem cells and to the final induced macrophage population. We then engineered a key gene encoding an enzyme in the myeloid cell antiviral pathway-SAMHD1-knockout (KO) hiPSCs and characterized the hiPSC line with RNA-Seq and induced macrophages from two distinct protocols with functional analysis. We then generated SAMHD1 KO CRISPR-dCAS9 KRAB hiPSCs through lentiviral transduction aiming to increase the efficiency of lentiviral mediated gene transfer. We demonstrated increased lentiviral transduction efficiency in induced macrophages, as well as microglia induced with two distinct protocols. This model allows for efficient gene knockdown, as well as large-scale functional genomics screens in mature hiPSC-derived macrophages or microglia with applications in innate immunity and chronic inflammatory disease biology. These experiments highlight the broad applicability of this platform for disease-relevant target identification and may improve our ability to run large-scale screens in hiPSC-derived myeloid model systems.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2025.1516626</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2025.1516626</link>
        <title><![CDATA[Enhanced renal ischemia/reperfusion injury repair potential of exosomes derived from B7-H1high mesenchymal stem cells]]></title>
        <pubdate>2025-04-02T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Jiahui He</author><author>Yawei Yao</author><author>Ruiyan Wang</author><author>Yujia Liu</author><author>Xingyu Wan</author><author>Hao Wang</author><author>Yuqiang Zhou</author><author>Wenjing Wang</author><author>Yan Ma</author><author>Xinghua Lv</author>
        <description><![CDATA[Two subgroups with high expression of B7-H1 and low expression of B7-H1 were successfully isolated from primitive human umbilical cord mesenchymal stem cells. And exosomes with high B7-H1 expression and low B7-H1 expression were successfully isolated. In comparison to the sham-operated group, mice in the IRI group demonstrated elevated serum levels of blood urea nitrogen (BUN) and serum creatinine (Scr), accompanied by a more pronounced degree of renal tissue damage. The administration of exosomes via the tail vein markedly accelerated the recovery of renal function in IRI mice, with the therapeutic effect beingmore pronounced in those treated with B7-H1high-Exo. Moreover RNA sequencing of mouse kidney treated with B7-H1high-Exo and B7-H1low-Exo showed that eight genes (C3, IRF7, AREG, CXCL10, Aldh1l2, Fnip2, Vcam1, St6galnac3) were involved in the pathophysiological process of ischemia-reperfusion injury. The in vitro and in vivo experiments showed that the expression level of C3 protein was significantly decreased, which indicated that B7-H1high-Exo played a therapeutic role by down-regulating C3.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1541992</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1541992</link>
        <title><![CDATA[Impacts of stem cells from different sources on wound healing rate in diabetic foot ulcers: a systematic review and meta-analysis]]></title>
        <pubdate>2025-01-28T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Le Tong</author><author>Lin Tang</author><author>Bangli Tang</author><author>Jianna Zhang</author>
        <description><![CDATA[BackgroundDiabetic foot ulcers (DFU) are a significant complication of diabetes, with huge implications on patient morbidity and healthcare costs. The objective of this meta-analysis was to evaluate the impacts of stem cells from different sources on wound healing rate in DFU patients.MethodsWe systematically retrieved records via key databases PubMed, Cochrane Library, Web of Science, Embase, China National Knowledge Infrastructure (CNKI) and Wanfang from the inception to October 2024. The Stata 16.0 (Stata Corp, TX) software was used to perform the meta-analysis. Risk of bias in all included studies was evaluated by Cochrane Risk of Bias version 2.ResultsA total of 24 studies involving 1,321 patients were included. There was an increased likelihood of wound healing with peripheral blood-derived stem cells, the most effective cells (odds ratios (OR) = 7.31, 95% CI: 2.90–18.47), followed by adipose-derived stem cells (OR = 5.23, 95% CI: 2.76–9.90), umbilical cord-derived stem cells (OR = 4.94, 95% CI: 0.61–40.03), bone-derived stem cells (OR = 4.36, 95% CI: 2.43–7.85) and other sources stem cells (OR = 3.16, 95% CI: 1.83–5.45). Nevertheless, only umbilical cord-derived stem cells showed statistical significance (p < 0.05). The heterogeneity ranged from non-existent in the adipose and peripheral blood groups (I2 = 0.00%) to moderate in the bone groups (I2 = 26.31%) and other groups (I2 = 30.62%), and substantial in the umbilical cord groups (I2 = 88.37%). Asymmetrical funnel plots pointed to publication bias, but the trim-and-fill method to correct for this brought the effect estimates even lower: based on the pooled OR, corrected OR was 3.40 (95% CI 2.39–4.84). Stem cell therapy was also associated with improvements in several secondary outcomes, suggesting its potential to influence the progression of DFU.ConclusionOur study suggested that stem cells from different sources showed potential in promoting wound healing in DFU, although with some variation in effectiveness. Despite some publication bias and moderate heterogeneity, the overall therapeutic effect remained positive. These findings indicated that stem cell therapy might influence the progression of DFU.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1407671</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1407671</link>
        <title><![CDATA[Identification of key miRNAs and target genes in extracellular vesicles derived from low-intensity pulsed ultrasound-treated stem cells]]></title>
        <pubdate>2025-01-15T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Xin Yin</author><author>Jialian Yi</author><author>Fugang Mao</author><author>Qisheng Tang</author><author>Xinyu Zhang</author><author>Xiaoyu Yang</author><author>Hongqing Xie</author><author>Linping Wang</author><author>Shuifen Sun</author><author>Xin Yu</author><author>Jie Liu</author><author>Lihong Jiang</author>
        <description><![CDATA[ObjectivesThis study aimed to investigate the impact of low-intensity pulsed ultrasound (LIPUS) treatment on the miRNA and mRNA profiles of stem cell-derived extracellular vesicles (EVs). Specifically, it sought to identify key miRNAs and their target mRNAs associated with enhanced therapeutic efficacy in LIPUS-treated stem cell-derived EVs.MethodsUtilizing miRNA deep-sequencing data from the Gene Expression Omnibus database, differential gene analysis was performed. MiRNA-mRNA target analysis, functional and pathway enrichment analysis, protein-protein interaction network construction, and hub gene identification were conducted. Validation of differentially expressed miRNAs was performed via RT-qPCR in human umbilical cord mesenchymal stem cells (hUC-MSCs) treated with LIPUS.ResultsTen differentially expressed miRNAs were identified, with six upregulated and four downregulated miRNAs in LIPUS-treated stem cell-derived EVs. Functional enrichment analysis revealed involvement in biological processes such as regulation of metabolic processes, cellular component organization, and response to stress, as well as signaling pathways like cell cycle, MAPK signaling, and Hippo signaling. Protein-protein interaction network analysis identified key hub genes including MYC, GAPDH, HSP90AA1, EP300, JUN, PTEN, DAC1, STAT3, HSPA8, and HIF1A associated with LIPUS treatment. RT-qPCR validation confirmed differential expression of selected miRNAs (hsa-miR-933, hsa-miR-3943, hsa-miR-4633-5p, hsa-miR-592, hsa-miR-659-5p, hsa-miR-4766-3p) in LIPUS-treated hUC-MSCs.ConclusionThis study sheds light on the potential therapeutic mechanisms underlying LIPUS-treated stem cell-derived EVs. The identified differentially expressed miRNAs and their potential target mRNAs offer valuable insights into the biological processes influenced by LIPUS treatment. While further investigation is necessary to validate their roles as therapeutic targets, this study lays the groundwork for future research on optimizing SC-EV therapy with LIPUS preconditioning.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1515778</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1515778</link>
        <title><![CDATA[Differential regulation of apoptosis-related genes during long-term culture and differentiation of canine adipose-derived stem cells - a functional bioinformatical analysis]]></title>
        <pubdate>2025-01-06T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Maurycy Jankowski</author><author>Katarzyna Stefańska</author><author>Michał Suchodolski</author><author>Claudia Dompe</author><author>Grzegorz Wąsiatycz</author><author>Bartosz Kempisty</author><author>Michał Nowicki</author><author>Magdalena Roszak</author>
        <description><![CDATA[IntroductionStem cells derived from adipose tissue are gaining popularity in the field of regenerative medicine due to their adaptability and clinical potential. Their rapid growth, ability to differentiate, and easy extraction with minimal complications make adipose-derived stem cells (ADSCs) a promising option for many treatments, particularly those targeting bone-related diseases. This study analyzed gene expression in canine ADSCs subjected to long-term culture and osteogenic differentiation.MethodsADSCs were isolated from discarded surgical waste and cultured for 14 days with and without differentiation media to assess osteogenic changes. RNA sequencing (RNA-seq) and bioinformatical analysis were performed to obtain comprehensive transcriptomic data. A total of 17793 genes were detected and GO enrichment analysis was performed on the differentially expressed genes to identify significantly up- and downregulated Biological Process (BP) GO terms across each comparison.ResultsThe upregulation of apoptosis-regulating genes and genes related to circulatory system development suggest an induction of these processes, while the downregulation of neurogenesis and gliogenesis genes points to reciprocal regulation during osteogenic differentiation of canine ADSCs.DiscussionThese findings underscore the potential of ADSCs in bone regeneration and offer valuable insights for advancing tissue engineering, however further studies, including proteomic analyses, are needed to confirm these patterns and their biological significance.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1538016</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1538016</link>
        <title><![CDATA[Corrigendum: Characterization of Strip1 expression in mouse cochlear hair cells]]></title>
        <pubdate>2024-12-20T00:00:00Z</pubdate>
        <category>Correction</category>
        <author>Shasha Zhang</author><author>Ying Dong</author><author>Ruiying Qiang</author><author>Yuan Zhang</author><author>Xiaoli Zhang</author><author>Yin Chen</author><author>Pei Jiang</author><author>Xiangyu Ma</author><author>Leilei Wu</author><author>Jingru Ai</author><author>Xia Gao</author><author>Pengjun Wang</author><author>Jie Chen</author><author>Renjie Chai</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1520519</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1520519</link>
        <title><![CDATA[Corrigendum: Advances in stem cell therapy for diabetic foot]]></title>
        <pubdate>2024-12-12T00:00:00Z</pubdate>
        <category>Correction</category>
        <author>Yinfeng Xia</author><author>Ping Wu</author><author>Hong Chen</author><author>Zhiyong Chen</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1421980</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1421980</link>
        <title><![CDATA[Two machine learning-derived nomogram for predicting the occurrence and severity of acute graft-versus-host disease: a retrospective study based on serum biomarkers]]></title>
        <pubdate>2024-11-08T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Qiang He</author><author>Xin Li</author><author>Yuan Fang</author><author>Fansheng Kong</author><author>Zhe Yu</author><author>Linna Xie</author>
        <description><![CDATA[BackgroundAcute graft-versus-host disease (aGVHD) is a common complication after allogeneic hematopoietic cell transplantation (allo-HSCT), with high morbidity and mortality. Although glucocorticoids are the standard treatment, only half of patients achieve complete remission. Thus, there is an urgent need to screen biomarkers for the diagnosis of aGVHD to assist in the identification of individuals at risk of aGVHD. This study was to construct prediction models for the occurrence and severity of aGVHD using two machine learning algorithms based on serum biochemical data.MethodsClinical data of 120 patients with hematological diseases who received allo-HSCT were retrospectively analyzed. Seventy-six patients developed aGVHD, including 56 grade I/II and 20 grade III/IV. First, 15 serum biochemical indicators were considered as potential risk factors, and the differences in the levels of indicators between non-aGVHD and aGVHD were observed, followed by evaluation of the diagnostic property. Subsequently, to develop the prediction models for the occurrence and severity of aGVHD, LASSO and random forest (RF) analyses were performed with experimental indicators. Finally, Venn diagram analysis was utilized to obtain shared biomarkers in the two algorithms to construct the nomogram. The model performance was measured by calibration curves. Internal and external validations were performed based on risk score models and ROC curve analyses.ResultsTotal 12 of 15 indicators exhibited significant differences between the aGVHD and non-aGVHD groups, with AUC values > 0.75. In machine learning analysis, eight features (LAG-3, TLR-2, PD-L1, IP-10, elafin, REG-3α, ST2, TIM3) and seven variables (LAG-3, TLR-2, PD-1, Flt_3, IL-9, elafin, TIM3) were selected to distinguish aGVHD vs. non-aGVHD as well as grade I/II vs. III/IV, respectively. Further, the corresponding nomogram models were established and calibration curves showed that prediction was in good agreement with the actual probability. Biomarker-based risk score model was constructed, which obtained AUC value >0.89 in internal and external datasets.ConclusionClinical variables screened through learning algorithm can predict the risk and severity of aGVHD. Our findings may help clinicians develop more personalized and reasonable management strategies.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fgene.2024.1427205</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fgene.2024.1427205</link>
        <title><![CDATA[Advances in stem cell therapy for diabetic foot]]></title>
        <pubdate>2024-09-03T00:00:00Z</pubdate>
        <category>Mini Review</category>
        <author>Yinfeng Xia</author><author>Ping Wu</author><author>Hong Chen</author><author>Zhiyong Chen</author>
        <description><![CDATA[Diabetic Foot Ulcers (DFU) represent a grave complication often encountered in the advanced stages of diabetes mellitus. They frequently lead to recurrent hospitalizations and, in severe cases, can result in life-threatening conditions such as infections, gangrene, and even amputation Diabetic foot ulcers (DFU), as a serious complication in the late stage of diabetes mellitus, are prone to lead to repeated hospitalization, and in severe cases, infection, gangrene, and even amputation. Although there are many methods for treating diabetic foot, there is no clear and effective method to reduce the amputation rate of diabetic foot patients. In recent years, advancements in the understanding of stem cell therapy for the treatment of DFU have shed light on its potential as a novel therapeutic approach. In recent years, as the research on stem cell therapy for diabetic foot is gradually deepening, stem cells are expected to become a new therapeutic method for treating DFU in the future. Their therapeutic effects are through promoting angiogenesis, secreting paracrine factors, controlling inflammation, promoting collagen deposition, and regulating immunity, etc. Despite numerous studies confirming the efficacy of stem cell therapy in treating DFU, there is still a need for the establishment of standardized treatment protocols. Although numerous studies have shown that stem cell therapy for DFU is real and effective, there has not yet been a standardized treatment protocol. This article reviews studies related to stem cell therapy for DFU, looking at the mechanism of action, types of stem cells, and modes of administration.]]></description>
      </item>
      </channel>
    </rss>